Animal models for COVID-19César Muñoz‐Fontela, Chien‐Te K. Tseng, William E. Dowling et al.|Nature|2020Cited by 877
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposingLaura Riva, Sumit K. Chanda, Shuofeng Yuan et al.|Nature|2020Cited by 856
SARS-CoV-2 spike E484K mutation reduces antibody neutralisationSonia Jangra, Michael Schotsaert, Chengjin Ye et al.|The Lancet Microbe|2021Cited by 435
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1AKris M. White, Adolfo García‐Sastre, Romel Rosales et al.|Science|2021Cited by 364
Virus-induced senescence is a driver and therapeutic target in COVID-19Soyoung Lee, Clemens A. Schmitt, Michael Mülleder et al.|Nature|2021Cited by 344